Latest stories

  • in

    Revise Phase I/II CT protocol: CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine

    Revise Phase I/II CT protocol: CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine

    New Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the vaccine major Serum Institute of India to revise the Phase I/II clinical trial protocol. This came after the firm presented its proposal to conduct of […] More

  • in

    Climate change spurring surge in dengue, chikungunya: WHO

    Climate change spurring surge in dengue, chikungunya: WHO

    The World Health Organization warned Wednesday that dengue and other diseases caused by mosquito-borne arboviruses were spreading far faster and further amid climate change, warning global outbreaks could be looming. Experts with the United Nations health agency sounded the alarm over swelling numbers of cases of dengue and chikungunya, and warned new epidemics of zika […] More